Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 414-418

  Zhang, Bing ^a   Fattah, A S M Abdul ^a   Nakama, Hidenori ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinicopathological characteristics; Colorectal cancer; Elderly patient; Immunochemical fecal occult blood test; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE STUDY; DEVICE; HISTOPATHOLOGY; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; OCCULT BLOOD; PREVALENCE; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADENOCARCINOMA; AGE FACTORS; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PROGNOSIS; SURVIVAL RATE;

EID: 0033998627     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 1 Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare: Vital Statistics of Japan. 1995; 1:270-275.
2. 2 Mandel JS, Bond JH, Church TR, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-1371.
3. 3 Nakam H: A study on the efficacy of a screening program for colorectal cancer in a small Japanese village. Clin Investig 1994; 72:117-121.
4. 4 Kronborg O, Fenger C, Olsen J, Jorgenson OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467-1471.
5. 5 Hardcastle JD, Chamberlain JO, Robinson MHE, et al: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
6. 6 Nelson RL, Dollear T, Freels S, Persky V: The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997; 80:193-197.
7. 7 Slusser SO, Liberski SM, McGarrity TJ: Survival of patients diagnosed with colorectal cancer through a television-advertised screening program. Am J Gastroenterol 1996; 91:1563-1566.
8. 8 Rhodes JB, Holmes FF, Clark GM: Changing distribution of primary cancers in the large bowel. JAMA 1977; 238:1641-1643.
9. 9 Snyder DN, Heston JF, Meigs JW, Flannery JT: Changes in site distribution of colorectal carcinoma in Connecticut, 1940-1973. Am J Dig Dis 1977; 22:791-797.
10. 10 Cady B, Persson AV, Monson DO, Maunz DL: Changing patterns of colorectal carcinoma. Cancer 1974; 33:422-426.
11. 11 Abrams JS, Reines HD: Increasing incidence of right-sided lesions in colorectal cancer. Am J Surg 1979; 137:522-526.
12. 12 Beart RW, Melton LJ, Maruta M, Dockerty MB, Frydenberg HB, O'Fallon WM: Trends in right and left-sided colon cancer. Dis Colon Rectum 1983; 26:393-398.
13. 13 Greene FL: Distribution of colorectal neoplasms: a left to right shift of polyps and cancer. Am Surg 1983; 49:62-65.
14. 14 Alley PG, McNee RK: Age and sex differences in right colon cancer. Dis Colon Rectum 1986;29:227-229.
15. 15 Slater G, Papatestas AE, Tartter PI, Mulvihill M, Aufses AH Jr: Age distribution of right-and left-sided colorectal cancers. Am J Gastroenterol 1982; 77:63-66.
16. 16 International classification of diseases, 9th revision, clinical modification. New York: McGraw Hill, 1994.
17. 17 Dukes CE: The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35:323-332.
18. 18 Turnbull RB Jr: Cancer of the colon: the five-and ten-year survival rates following resection utilizing the isolation technique. Ann R Coll Surg Engl 1970; 46:243-250.
19. 19 Schub R, Steinhaber FU: Rightward shift of colon cancer: a feature of the the aging gut. J Clin Gastroenterol 1986; 8:630-634.
20. 20 Fleishner P, Slater G, Aufses AH Jr: Age and sex distribution of patients with colorectal cancer. Dis Colon Rectum 1989; 32:107-111.
21. 21 Vobecky J, Leduc C, Devroede G: Sex differences in the changing anatomic distribution of colorectal carcinoma. Cancer 1984; 54:3065-3069.
22. 22 Halvorsen TB: Site distribution of colorectal adenocarcinornas. Scand J Gastroenterol 1986; 21:973-978.
23. 23 Capocaccia R, Angelis RD, Frova L, et al: Estimation and projections of colorectal cancer trends in Italy. Int J Epidemiol 1997; 26:924-932.
24. 24 Heston JF, Kelley JA, Meigs JW, Flannery JT: Forty-five years of cancer incidence in Connecticut: 1935-79. Nat Cancer Inst Monogr 1986; 70:204-253.
25. 25 Dodging UW, Cay NE, Muir CS, et al: The distribution of cancer within the large bowel. Int J Cancer 1972; 10:463-477.
26. 26 Macrae FA, John DJB: Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers and adenomas. Gastroenterology 1982; 82:891-898.
27. 27 Doran J, Hardcastle JC: Bleeding patterns in colorectal cancer: the effect of aspirin and implications for fecal occult blood testing. Br J Surg 1982; 69:711-713.
28. 28 Goldschmiedt M, Ahlquist DA, Wieand HS, et al: Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding: appraisal of its clinical utility. Dig Dis Sci 1988; 33:605-608.
29. 29 Mandel JS, Bond JH, Bradley M, et al: Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancer: the University of Minnesota's colon cancer control study. Gastroenterology 1989; 97:597-600.
30. 30 Nakama H, Kamijo N, Fujimori K, Horiuchi A, Fattah ASMA, Zhang B: Characteristics of colorectal cancer with false negative result on immunochemical faecal occult blood test. JMed Screen 1996; 3:115-118.
31. 31 Chapuis PH, Newland RC, MacPherson JG, Dent O, Payne JE, Pheils MT: The distribution of colorectal carcinoma and the relationship of tumour site to the survival of patients following resection. Aust NZ J Surg 1981; 51:127-131.
32. 32 Alley PG: Large bowel cancer in Auckland, New Zealand 1965-1975. NZ Med J 1981; 94:131-133.
33. 33 Kune GA, Kune S, Field B, et al: Survival in patients with large-bowel cancer: a population-based investigation from the Melbourne colorectal cancer study. Dis Colon Rectum 1990; 33:938-946.
34. 34 Wolmark N, Wieand HS, Rockette HE: The prognostic significance of tumor and location and bowel obstruction in Dukes' B and C colorectal cancer: findings from the NSABP clinical trials. Ann Surg 1983; 198:743-752.
35. 35 Goodwin JS, Samel JM, Hunt WC: Determinants of survival in older cancer patients. J Natl Cancer Inst 1996; 88:1031-1038.
36. 36 Goodwin JS, Hunt WC, Samet JM: Determinants of cancer therapy in elderly patients. Cancer 1993; 72:594-601.
37. 37 Wetle T: Age as a risk factor for inadequate treatment. JAMA 1987; 258:516.
38. 38 Samet J, Hunt WC, Key C, Humble CG, Goodwin JS: Choice of cancer therapy varies with age of patient. JAMA 1986; 255:3385-3390.
39. 39 Mayberry RM, Coates RJ, Hill HA, et al: Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 1995; 87:1686-1693.
40. 40 Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG: Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85:1311-1318.
41. 41 Spratt JS, Spjut HJ: Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 1967; 20:1976-1985.
42. 42 Berge T, Ekelund G, Mellner C, Pihl B, Wenckert A: Carcinoma of the colon and rectum in a defined population: an epidemiological, clinical and postmortem investigation of colorectal carcinoma and coexisting benign polyps in Malmo, Sweden. Acta Chir Scand 1973; 438(Suppl):1-86.